A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/513 (2006.01) A61K 31/4418 (2006.01) A61P 31/18 (2006.01)
Patent
CA 2588466
A method for improving the pharmacokinetics of an orally administered drug that is directly metabolized by UGT1A1 comprises orally administering to a mammal in need of treatment with the drug a combination of the drug or a pharmaceutically acceptable salt thereof and atazanavir or a pharmaceutically acceptable salt thereof.
L'invention concerne un procédé destiné à améliorer les propriétés pharmacocinétiques d'un médicament à administration orale, métabolisé directement par UGT1A1. Ledit procédé consiste à administrer par voie orale, à un mammifère nécessitant un traitement par ce médicament, une combinaison dudit médicament ou d'un sel pharmaceutiquement acceptable dudit médicament et d'atazanavir ou d'un sel pharmaceutiquement acceptable d'atazanavir.
Gowling Lafleur Henderson Llp
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
LandOfFree
Use of atazanavir for improving the pharmacokinetics of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of atazanavir for improving the pharmacokinetics of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of atazanavir for improving the pharmacokinetics of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1722389